Postprandial chylomicrons and VLDLs in severe hypertriacylglycerolemia are lowered more effectively than are chylomicron remnants after treatment with n−3 fatty acids
Open Access
- 1 April 2000
- journal article
- research article
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 71 (4) , 914-920
- https://doi.org/10.1093/ajcn/71.4.914
Abstract
Background: n−3 Fatty acids lower plasma triacylglycerols not only in the fasting state but also in the postprandial state. However, it is not known whether chylomicrons, chylomicron remnants, and VLDLs are all affected equally or whether some lipoprotein species are lowered preferentially. Objective: Lipoproteins, including large and small chylomicron remnants, were determined specifically with the aid of a newly developed method involving a combination of size-exclusion chromatography and fluorometric determination of retinyl palmitate, which served as a marker for exogenous fat. Design: Twelve hypertriacylglycerolemic men were treated for 6 wk with 4 capsules containing 85% fish-oil concentrate/d; each capsule contained 850 mg n−3 fatty acid ethyl esters (49.1% eicosapentaenoic acid by wt and 32.2% docosahexaenoic acid by wt). Oral-fat-tolerance tests were performed before and after the treatment. Blood samples were drawn in the fasting state and until 8 h postprandially. Results: Treatment with n−3 fatty acids reduced the fasting VLDL-triacylglycerol concentration by 44% (P < 0.05) and postprandial chylomicrons and VLDLs at 4, 6, and 8 h (P < 0.05) by 49–64% and 36–43%, respectively. Chylomicron remnants were reduced only in the late postprandial phase: large chylomicron remnants by 19% at 6 h and by 43% at 8 h (P < 0.05) and small chylomicron remnants by 31% at 8 h (P < 0.05). Conclusion: n−3 Fatty acids effectively lower chylomicrons and VLDLs, but their effect on chylomicron remnants was observed only in the late postprandial phase.Keywords
This publication has 34 references indexed in Scilit:
- Clearance of postprandial lipoproteins in normolipemics: role of the apolipoprotein E phenotypeBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
- Changes of n − 3 and n − 6 fatty acids in plasma and circulating cells of normal subjects, after prolonged administration of 20:5 (EPA) and 22:6 (DHA) ethyl esters and prolonged washoutBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1993
- Chylomicron-retinyl palmitate clearance in type I hyperlipidemic families.Journal of Clinical Investigation, 1991
- Fish oil supplementation reduces beta-very low density lipoprotein in type III dysbetalipoproteinemia.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- Effect of eicosapentaenoic acid on triacylglycerol transport in CaCo-2 cellsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990
- Comparative effects of dietary fish oil and carbohydrate on plasma lipids and hepatic activities of phosphatidate phosphohydrolase, diacylglycerol acyltransferase and neutral lipase activities in the ratBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1987
- Reduction of Plasma Lipids, Lipoproteins, and Apoproteins by Dietary Fish Oils in Patients with HypertriglyceridemiaNew England Journal of Medicine, 1985
- Uptake of chylomicron remnants causes cholesterol accumulation in cultured human arterial smooth muscle cellSBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1981
- TYPE-III HYPERLIPOPROTEINÆMIA ("REMNANT REMOVAL DISEASE")The Lancet, 1977
- Evidence for a Common, Saturable, Triglyceride Removal Mechanism for Chylomicrons and Very Low Density Lipoproteins in ManJournal of Clinical Investigation, 1973